Indication
Radiodermatitis
**Radiodermatitis** (also known as radiation dermatitis or radiation-induced skin injury) is an inflammatory cutaneous complication resulting from exposure to ionizing radiation, most frequently encountered in oncology patients undergoing therapeutic radiation. Read more about Radiodermatitis
0 drugs 0 manufacturers
Drugs that treat it
Common Radiodermatitis therapies.
No drugs are available
This indication does not currently contain public drugs.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon**Radiodermatitis** (also known as radiation dermatitis or radiation-induced skin injury) is an inflammatory cutaneous complication resulting from exposure to ionizing radiation, most frequently encountered in oncology patients undergoing therapeutic radiation.
Pathophysiologically, ionizing radiation induces DNA damage, generates reactive oxygen species, and depletes rapidly dividing basal keratinocytes and vascular endothelial cells, triggering a cascade of proinflammatory and profibrotic cytokines.
Clinically, it manifests along a spectrum ranging from acute erythema, edema, pruritus, and dry or moist desquamation to chronic changes characterized by skin atrophy, telangiectasias, dyspigmentation, ulceration, and radiation-induced fibrosis.
- nih.gov
**Radiodermatitis** (also known as radiation dermatitis or radiation-induced skin injury) is an inflammatory cutaneous complication resulting from exposure to ionizing radiation, most frequently encountered in oncology patients undergoing therapeutic radiation
- dermnetnz.org
**Radiodermatitis** (also known as radiation dermatitis or radiation-induced skin injury) is an inflammatory cutaneous complication resulting from exposure to ionizing radiation, most frequently encountered in oncology patients undergoing therapeutic radiation Pathophysiologically, ionizing radiation induces DNA damage, generates reactive oxygen species, and depletes rapidly dividing basal keratinocytes and vascular endothelial cells, triggering a cascade of proinflammatory and profibrotic cytok...
- nih.gov
Pathophysiologically, ionizing radiation induces DNA damage, generates reactive oxygen species, and depletes rapidly dividing basal keratinocytes and vascular endothelial cells, triggering a cascade of proinflammatory and profibrotic cytokines Clinically, it manifests along a spectrum ranging from acute erythema, edema, pruritus, and dry or moist desquamation to chronic changes characterized by skin atrophy, telangiectasias, dyspigmentation, ulceration, and radiation-induced fibrosis
- bccancer.bc.ca
Pathophysiologically, ionizing radiation induces DNA damage, generates reactive oxygen species, and depletes rapidly dividing basal keratinocytes and vascular endothelial cells, triggering a cascade of proinflammatory and profibrotic cytokines
- cancernetwork.com
Clinically, it manifests along a spectrum ranging from acute erythema, edema, pruritus, and dry or moist desquamation to chronic changes characterized by skin atrophy, telangiectasias, dyspigmentation, ulceration, and radiation-induced fibrosis
- myamericannurse.com
Clinically, it manifests along a spectrum ranging from acute erythema, edema, pruritus, and dry or moist desquamation to chronic changes characterized by skin atrophy, telangiectasias, dyspigmentation, ulceration, and radiation-induced fibrosis
- dovepress.com
Clinically, it manifests along a spectrum ranging from acute erythema, edema, pruritus, and dry or moist desquamation to chronic changes characterized by skin atrophy, telangiectasias, dyspigmentation, ulceration, and radiation-induced fibrosis
Personalize your experience
Follow Radiodermatitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.